I’m a holder of rgs but I tend to agree. No quantitative data in announcement and no news as to where next. More information is needed before a rerate. Though given our cash position and number of products in the pipeline I’m happy to keep this one in the bottom draw.
Ann: Regeneus Announces Successful Results in Acne Study, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
